A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

This article, presented in the backdrop of the debates on the state of political theory in India, argues that the terms of debate need to shift to include the question of method of doing political ...

Far beyond novelty or experiment, 2025 was the year that crossover projects rejected genre labels for endless sonic possibilities, writes Stewart Smith in The Wire 503/504 ...

A secretive scientist, Dr “Hap” Percy, studies people with near-death histories to test if consciousness can cross dimensions ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

Fruchter, G. (2026) Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach. Modern Economy, 17, 26-38.

One of the key learning outcomes of university education in general, and liberal arts programmes,  in particular, is that ...

We introduce a new benchmark, MoToMQA, to assess human and LLM ToM abilities at increasing orders. MoToMQA is based upon the format of the Imposing Memory Task (IMT), a well-validated psychological ...